Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Short-term Investments: 2011-2016

Historic Short-term Investments for EyePoint Pharmaceuticals (EYPT) over the last 6 years, with Jun 2016 value amounting to $13.7 million.

  • EyePoint Pharmaceuticals' Short-term Investments fell 70.27% to $2.5 million in Q1 2017 from the same period last year, while for Mar 2017 it was $2.5 million, marking a year-over-year decrease of 70.27%. This contributed to the annual value of $13.7 million for FY2016, which is 45.30% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Short-term Investments of $13.7 million as of FY2016, which was up 45.30% from $9.4 million recorded in FY2015.
  • EyePoint Pharmaceuticals' Short-term Investments' 5-year high stood at $13.7 million during FY2016, with a 5-year trough of $2.9 million in FY2014.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Short-term Investments value was $9.4 million (recorded in 2015), while the average stood at $8.7 million.
  • In the last 5 years, EyePoint Pharmaceuticals' Short-term Investments plummeted by 66.09% in 2013 and then soared by 219.77% in 2015.
  • Over the past 5 years, EyePoint Pharmaceuticals' Short-term Investments (Yearly) stood at $10.0 million in 2012, then plummeted by 66.09% to $3.4 million in 2013, then dropped by 12.77% to $2.9 million in 2014, then soared by 219.77% to $9.4 million in 2015, then spiked by 45.30% to $13.7 million in 2016.